Jason Wen
Interventional Cardiology · Cleveland, OHNPI 1760910244
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Abbott at 48.9% of the total. Reporting peaked in 2024 at $21,860 and has fallen 54.4% since, to $9,964 in 2025.
Across 216 payments — averaging $172.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$18K
- Medtronic$7K
- Penumbra, Inc.$3K
- Shockwave Medical, Inc$2K
- Abiomed$2K
- Edwards Lifesciences$2K
- plus $4K from 20 others
What the payments were for
- Grants$20,92156%
- Travel & lodging$3,97811%
- Food & beverage$12,22633%
- Education$2351%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 55 | $18,252 |
| Medtronic(2 entities) | 11 | $6,610 |
| Penumbra, Inc. | 8 | $2,658 |
| Shockwave Medical, Inc | 34 | $2,199 |
| Abiomed | 30 | $2,090 |
| Edwards Lifesciences | 17 | $1,647 |
| Boston Scientific | 4 | $1,558 |
| Heartflow, Inc. | 4 | $576 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $366 |
| Recor Medical Inc | 3 | $231 |
| Philips North America LLC | 5 | $210 |
| AbbVie | 1 | $161 |
| Novartis | 8 | $139 |
| Amgen | 6 | $126 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $123 |
| Pfizer | 3 | $118 |
| Impulse Dynamics (USA) Inc. | 1 | $55 |
| W. L. Gore & Associates, Inc. | 1 | $50 |
| Johnson & Johnson | 2 | $35 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Asahi Intecc USA, Inc. | 2 | $30 |
| Canon Medical Systems USA, Inc. | 1 | $24 |
| Inari Medical, Inc. | 1 | $21 |
| AstraZeneca | 1 | $19 |
| Cardiva Medical, Inc. | 1 | $14 |
| Terumo Medical Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,542
- OPTIS$1,243
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$925
- CARDIOMEMS$794
- ENSITE PRECISION$594
- FFRct$526
- SAPIEN 3 Ultra RESILIA$492
- PASCAL$418
- Impella$242
- EVOQUE$209
- ONYX FRONTIER$164
- OZURDEX$161
- Edwards SAPIEN 3 Transcatheter Heart Valve$158
- PRESSUREWIRE$150
- Paradise Ultrasound Renal Denervation System$136
- ARCALYST$123
- Sentinel$121
How this compares
$37,360 in reported general payments places this provider in the 80th percentile of 256 interventional cardiology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Cleveland
- Grant ReedCleveland$235K
- Rishi PuriCleveland$185K
- Rayji TsutsuiCleveland$100K
- Paul PoommipanitCleveland$97K
- Jun LiCleveland$85K
- Michael ChenierCleveland$76K
- Khaled ZiadaCleveland$53K
- Laura YoungCleveland$51K
- Bernardo CorteseCleveland$45K
- Khanjan ShahCleveland$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.